Edition:
United Kingdom

Autolus Therapeutics PLC (AUTL.OQ)

AUTL.OQ on NASDAQ Stock Exchange Global Select Market

29.20USD
15 Feb 2019
Change (% chg)

$-0.25 (-0.85%)
Prev Close
$29.45
Open
$29.70
Day's High
$30.00
Day's Low
$28.89
Volume
8,624
Avg. Vol
16,210
52-wk High
$53.14
52-wk Low
$19.33

Latest Key Developments (Source: Significant Developments)

Autolus Therapeutics Enters Lease With Alexandria Real Estate Equities, Inc. For Future Commercial-Scale Manufacturing Site And U.S. Headquarters
Monday, 14 Jan 2019 

Jan 14 (Reuters) - Alexandria Real Estate Equities Inc ::AUTOLUS THERAPEUTICS ENTERS LEASE WITH ALEXANDRIA REAL ESTATE EQUITIES, INC. FOR FUTURE COMMERCIAL-SCALE MANUFACTURING SITE AND U.S. HEADQUARTERS.AUTOLUS THERAPEUTICS PLC - NEW FACILITY WILL HAVE A PLANNED CAPACITY TO PRODUCE 5,000 T CELL THERAPIES ANNUALLY.AUTOLUS THERAPEUTICS PLC - ESTABLISHED A TEMPORARY U.S. HEADQUARTERS IN ROCKVILLE UNTIL NEW FACILITY IS READY FOR OCCUPANCY.AUTOLUS THERAPEUTICS PLC - IS ALSO INITIATING BUILD-OUT OF A MANUFACTURING FACILITY IN ENFIELD, U.K. THAT WILL OPEN IN 2020.AUTOLUS THERAPEUTICS PLC - OCCUPANCY OF NEW FACILITY IS EXPECTED TO OCCUR IN 2021.  Full Article

UK biotech raises bumper $2 billion, despite Brexit blues

LONDON Britain's biotechnology industry has raised a bumper 1.56 billion pounds in the first eight months of this year, surpassing the 1.2 billion reached in the whole of 2017, despite anxiety in the sector about the fallout from Brexit.